Company / Free Cash Flow
Boston Scientific Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$3.7B
FY2025
5-year range
$938.0M / $3.7B
FY2021-FY2025
Trend
+38.3%
vs FY2024
Sector context
#10 of 151
Health Care
What the data says
Among 151 Health Care companies, Boston Scientific is in the top 7% for free cash flow. Free Cash Flow has increased for 3 consecutive years, from $938M in FY2022 to $3.7B in FY2025.
Based on SEC 10-K filings.
$3.7B in FY2025 with a 3-year CAGR of +57.4%. Top quartile in the Health Care sector.
Improved from $1.8B to $3.7B over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +57.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 151This company $3.7B Sector average $779.8M
▼
+369.1% above sector average
Key checks
Key Insights
- Boston Scientific's free cash flow has grown for 3 consecutive years.
- 3-year CAGR of +57.4%, indicating consistent growth.
- In FY2025, free cash flow increased 38.3% year-over-year.
- Ranks #10 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.7B | +38.3% |
| FY2024 | $2.6B | +47.6% |
| FY2023 | $1.8B | +91.0% |
| FY2022 | $938.0M | -31.8% |
| FY2021 | $1.4B | +23016.7% |
| FY2020 | -$6.0M | -100.4% |
| FY2019 | $1.4B | +23016.7% |
| FY2018 | -$6.0M | -100.5% |
| FY2017 | $1.1B | +37.3% |
| FY2016 | $806.0M | +81.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026